Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Quantitative microbial risk assessment of antibacterial hand hygiene products on risk of shigellosis.

Schaffner DW, Bowman JP, English DJ, Fischler GE, Fuls JL, Krowka JF, Kruszewski FH.

J Food Prot. 2014 Apr;77(4):574-82. doi: 10.4315/0362-028X.JFP-13-366.

PMID:
24680068
2.

Limitations of plasma human immunodeficiency virus RNA testing.

Krowka JF, Sheppard HW, Ascher MS, Hallowitz R.

Clin Infect Dis. 2000 Nov;31(5):1317-8. No abstract available.

PMID:
11073782
3.

CD4+ T cell surface CCR5 density and virus load in persons infected with human immunodeficiency virus type 1.

Marmor M, Krowka J, Goldberg JD.

J Infect Dis. 2000 Oct;182(4):1284-6. No abstract available.

PMID:
10979936
4.

Dissociation of immunologic and virologic responses to highly active antiretroviral therapy.

Fessel WJ, Krowka JF, Sheppard HW, Gesner M, Tongson S, Weinstein S, Ascher M, Kwok S, Christopherson C.

J Acquir Immune Defic Syndr. 2000 Apr 1;23(4):314-20.

PMID:
10836753
5.

PCR-Based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells.

Christopherson C, Kidane Y, Conway B, Krowka J, Sheppard H, Kwok S.

J Clin Microbiol. 2000 Feb;38(2):630-4.

6.

Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors.

Betts MR, Krowka JF, Kepler TB, Davidian M, Christopherson C, Kwok S, Louie L, Eron J, Sheppard H, Frelinger JA.

AIDS Res Hum Retroviruses. 1999 Sep 1;15(13):1219-28.

PMID:
10480635
7.

Genetic and immunological host factors associated with susceptibility to HIV-1 infection.

Buchacz KA, Wilkinson DA, Krowka JF, Koup RA, Padian NS.

AIDS. 1998;12 Suppl A:S87-94. Review.

PMID:
9632989
8.

Lack of associations of chemotactic cytokines with viral burden, disease progression, or lymphocyte subsets in HIV-infected individuals.

Krowka JF, Gesner ML, Ascher MS, Sheppard HW.

Clin Immunol Immunopathol. 1997 Oct;85(1):21-7.

PMID:
9325065
9.

Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians.

Betts MR, Krowka J, Santamaria C, Balsamo K, Gao F, Mulundu G, Luo C, N'Gandu N, Sheppard H, Hahn BH, Allen S, Frelinger JA.

J Virol. 1997 Nov;71(11):8908-11.

10.

Molluscum contagiosum virus grows in human skin xenografts.

Paslin D, Krowka J, Forghani B.

Arch Dermatol Res. 1997 Jul;289(8):486-8. No abstract available.

PMID:
9266028
11.

Immunotherapy for HIV.

Krowka JF, Sheppard HW, Ascher MS.

Lancet. 1997 Feb 8;349(9049):434. No abstract available.

PMID:
9033497
12.

Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals.

Krowka JF, Cuevas B, Maron DC, Steimer KS, Ascher MS, Sheppard HW.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jan 1;11(1):95-104.

PMID:
8528739
13.

Deficiency in T cell responses of human fetal lymph node cells: a lack of accessory cells.

von Hoegen P, Sarin S, Krowka JF.

Immunol Cell Biol. 1995 Aug;73(4):353-61.

PMID:
7493773
14.

HIV results in the frame. Paradox remains.

Ascher MS, Sheppard HW, Anderson RW, Krowka JF, Bremermann HJ.

Nature. 1995 May 18;375(6528):196; author reply 198. No abstract available.

PMID:
7746317
15.

AIDS as immune system activation. Key questions that remain.

Ascher MS, Sheppard HW, Krowka JF, Bremermann HJ.

Adv Exp Med Biol. 1995;374:203-10. Review.

PMID:
7572393
16.

Viral burden and HIV disease.

Sheppard HW, Ascher MS, Krowka JF.

Nature. 1993 Jul 22;364(6435):291-2. No abstract available.

PMID:
8101354
17.

Immunological characteristics of the putative CD4-binding site of the HIV-1 envelope protein.

Kieber-Emmons T, Krowka JF, Boyer J, Ugen KE, Williams WV, Morrow WJ, Weiner DB.

Pathobiology. 1992;60(4):187-94.

PMID:
1388715
18.

Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse.

Vandekerckhove BA, Krowka JF, McCune JM, de Vries JE, Spits H, Roncarolo MG.

J Immunol. 1991 Jun 15;146(12):4173-9.

PMID:
1674954
19.

Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent.

Krowka JF, Sarin S, Namikawa R, McCune JM, Kaneshima H.

J Immunol. 1991 Jun 1;146(11):3751-6.

PMID:
1827814
20.

Epitopes of human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins recognized by antibodies in the sera of HIV-1-infected individuals.

Krowka JF, Singh B, Stites DP, Maino VC, Narindray D, Hollander H, Jain S, Chen H, Blackwood L, Steimer KS.

Clin Immunol Immunopathol. 1991 Apr;59(1):53-64.

PMID:
1708316
21.

The SCID-hu mouse: a small animal model for HIV infection and pathogenesis.

McCune J, Kaneshima H, Krowka J, Namikawa R, Outzen H, Peault B, Rabin L, Shih CC, Yee E, Lieberman M, et al.

Annu Rev Immunol. 1991;9:399-429. Review.

PMID:
1910684
22.

Monocyte-mediated lysis of HIV-infected tumor cells.

Debs RJ, Krowka J, Stites D, Brunette EN, Düzgünes N, Philip R.

AIDS Res Hum Retroviruses. 1990 Aug;6(8):1005-9.

PMID:
1699572
23.

Lymphocyte proliferative responses to soluble and liposome-conjugated envelope peptides of HIV-1.

Krowka J, Stites D, Debs R, Larsen C, Fedor J, Brunette E, Düzgünes N.

J Immunol. 1990 Apr 1;144(7):2535-40.

PMID:
1969450
24.

Long-term observation of baboons, rhesus monkeys, and chimpanzees inoculated with HIV and given periodic immunosuppressive treatment.

Morrow WJ, Homsy J, Eichberg JW, Krowka J, Pan LZ, Gaston I, Legg H, Lerche N, Thomas J, Levy JA.

AIDS Res Hum Retroviruses. 1989 Apr;5(2):233-45.

PMID:
2713168
25.

Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro.

Krowka JF, Stites DP, Jain S, Steimer KS, George-Nascimento C, Gyenes A, Barr PJ, Hollander H, Moss AR, Homsy JM, et al.

J Clin Invest. 1989 Apr;83(4):1198-203.

26.

Immunological effects of HIV infection.

Krowka JF, Moody DJ, Stites DP.

Immunol Ser. 1989;44:257-303. Review. No abstract available.

PMID:
2535143
27.

Relation of circulating levels of human immunodeficiency virus (HIV) antigen, antibody to p24, and HIV-containing immune complexes in HIV-infected patients.

McHugh TM, Stites DP, Busch MP, Krowka JF, Stricker RB, Hollander H.

J Infect Dis. 1988 Nov;158(5):1088-91. No abstract available. Erratum in: J Infect Dis 1989 Mar;159(3):602.

PMID:
3141521
28.

Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus.

Krowka J, Stites D, Mills J, Hollander H, McHugh T, Busch M, Wilhelm L, Blackwood L.

Clin Exp Immunol. 1988 May;72(2):179-85.

29.

Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event.

Serra HM, Krowka JF, Ledbetter JA, Pilarski LM.

J Immunol. 1988 Mar 1;140(5):1435-41.

PMID:
2964476
30.

Interrelations of lymphocyte subset values, human immunodeficiency virus antibodies, and HIV antigen levels of homosexual males in San Francisco.

Krowka JF, Stites DP, Moss AR, Casavant CH, Carlson JR, Chermann JC, Barre-Sinoussi F, Rodgers RP, Bacchetti P, McHugh TM, et al.

Diagn Clin Immunol. 1988;5(6):381-7.

PMID:
3219786
31.

In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma.

Wong GH, Krowka JF, Stites DP, Goeddel DV.

J Immunol. 1988 Jan 1;140(1):120-4.

PMID:
3121735
32.

Soluble antigen-specific helper molecules active in the induction of cytotoxic T lymphocytes.

Pilarski LM, Krowka JF, Deans JP.

Ann N Y Acad Sci. 1988;532:136-48. Review. No abstract available.

PMID:
2972240
33.

The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro.

Shalaby MR, Krowka JF, Gregory TJ, Hirabayashi SE, McCabe SM, Kaufman DS, Stites DP, Ammann AJ.

Cell Immunol. 1987 Nov;110(1):140-8.

PMID:
2824064
34.

Comparative functional analysis of helper T lymphocyte responses to soluble and particulate antigens.

Krowka JF, Guidos C, Sinha A, Lee KC, Diener E, Pilarski LM.

J Immunol. 1987 May 15;138(10):3114-9.

PMID:
2952708
35.

Antigen-specific helper factor reacts with antibody to the T-cell receptor.

Deans JP, Krowka JF, Mosmann T, Pilarski LM.

J Immunogenet. 1987 Apr-Jun;14(2-3):103-7.

PMID:
2447186
37.
38.

Abnormal clonogenic potential of T cells from multiple myeloma patients.

Pilarski LM, Mant MJ, Ruether BA, Carayanniotis G, Otto D, Krowka JF.

Blood. 1985 Dec;66(6):1266-71.

PMID:
3904868
39.

Induction of cytotoxic lymphocyte responses by antigen-specific helper factors.

Krowka JF, Shiozawa C, Diener E, Paetkau V, Pilarski LM.

J Immunol. 1984 Oct;133(4):2018-24.

PMID:
6206146

Supplemental Content

Loading ...
Support Center